Turmeric may fight bladder cancer
Scientists have found that Turmeric inhibits various kinds of cancer in laboratory
and animal studies. In this study bladder cancer was given to rats. Separately
the scientists found that adding Turmeric to human bladder cancer cells stopped
them from growing and caused them to die. The cancer killing ability of Turmeric
was better than the powerful chemotherapeutic drug Cisplatin. Large-dose and
short-term use of Turmeric was lethal to human bladder cancer cells. In the
animals Turmeric was also killing the bladder cancer; it inhibited and slowed
the growth of the cancer showing that Turmeric could prove to be an effective
agent for helping prevent and treat bladder cancer. The study is published in
the March 12th 2008 issue of Cancer Letters.
Strontium reduces back pain in women with arthritis of the spine
The mineral Strontium may reduce back pain in women with osteoporosis and osteoarthritis
(OA) of the spine, according to this newly published study. The compound may
also delay worsening arthritis of the spine.
Strontium has a compound effect on bone and it stimulates bone formation while
inhibiting bone resorption whereas drugs either accomplish one activity or the
other usually the latter.
Dr. Olivier Bruyere from University of Liege, Belgium and colleagues explain
their findings "Strontium ranelate may have symptom- and structure-modifying
effects in women with osteoporosis and OA."
The investigators reviewed the effects of 3 years' treatment with Strontium
ranelate on the clinical and structural progression of spinal OA in 1105 women.
As participants in the Spinal Osteoporosis Therapeutic Intervention and Treatment
of Peripheral Osteoporosis trials, 566 women had received Strontium ranelate
and 539 had received placebo.
The researchers found that the proportion of women with worsening overall spinal
OA score was reduced by 42 percent in the Strontium ranelate group relative
to the placebo group.
In addition, significantly more women in the Strontium ranelate group saw improvement
in back pain after 3 years compared with placebo.
"This study has implications not only in the potential treatment of chronic
back pain, but also for progression of OA at other sites," the researchers
Strontium is indicated for the treatment of postmenopausal osteoporosis and
has been shown to reduce the risk of fractures the researchers note. They point
out that Strontium is also being studied in patients with OA of the knee. The
study is published in the March 2008 issue of the journal Annals of the